benzoyl-l-tyrosyl-[1-13c]alanine
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT01259544)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 13-carbon
Oral
No
Parenteral
No
Topical
No
Also known as
- benzoyl-l-tyrosyl-[1-13c]alanine
- benzoyl-l-tyrosyl-[1-13c]alanine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01259544 | Phase 2 | Jan 1, 2009 | Asian Institute of Gastroenterology, Exalenz Bioscience LTD., Virginia Commonwealth University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Asian Institute of Gastroenterology | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Exalenz Bioscience LTD. | For profit | 1 | 1 | 1 | 2009 |
| Virginia Commonwealth University | Academic/Hospital | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1